Genome-wide DNA methylation and gene expression are commonly altered in pediatric acute 23 lymphoblastic leukemia (PALL). Integrated analysis of cytosine methylation and expression 24 datasets has the potential to provide deeper insights into the complex disease states and their 25 Pathways in cancer, Ras signaling pathway, PI3K-Akt signaling pathway, and Rap1 signaling 29 pathway, among others. Detected gene hubs and hub sub-networks are integrated by signature 30 loci associated with cancer that include, for example, NOTCH1, RAC1, PIK3CD, BCL2, and 31 EGFR. Statistical analysis disclosed a stochastic deterministic dependence between methylation 32 and gene expression within the set of genes simultaneously identified as DEGs and DMGs, 33 where larger values of gene expression changes are probabilistically associated with larger 34 values of methylation changes. Concordance analysis of the overlap between enriched pathways 35 in DEG and DMG datasets revealed statistically significant agreement between gene expression 36 and methylation changes, reflecting a coordinated response of methylation and gene-expression 37 regulatory systems. These results support the identification of reliable and stable biomarkers for 38 cancer diagnosis and prognosis. 39 42 cost effective approaches for early disease detection, prediction of co-occurring diseases and 43 interactions, and drug design 1 . Although integrated genomic analysis of methylation and gene 44 expression in leukemia have been performed 2-5 , an integration including network analysis of 45 methylation and gene expression is still missing. 46
causes than individual disconnected analyses. Studies of protein-protein interaction (PPI) 26 networks of differentially methylated (DMGs) and expressed genes (DEGs) showed that gene 27 expression and methylation consistently targeted the same gene pathways associated with cancer: 28 Introduction 40 Network-based modeling approaches have the potential to integrate and improve the perception 41 of complex disease states and their root causes. To date, network analysis provides reliable and
Results

68
General methylation features of the study 69 Differentially methylated positions (DMPs) were estimated for control (four normal CD19+ 70 blood cell donors) and patient (ALL cells from three patients) groups relative to a reference 71 group of four independent normal CD19+ blood cell donors. Inclusion of a reference group 72 permitted the evaluation of natural variation in healthy individuals and reduction of noise in a 73 signal detection step of our methylation analysis pipeline. The distribution of methylation 74 changes at DMPs along the chromosome revealed a genome-wide methylation re-patterning 75 dominated by hypermethylation in PALL patients ( Supplementary Fig. S1 ). Hypomethylated 76 sites are visible in the genome browser after zooming (tracks available in the Supplementary File 77 S1). Consistent with natural methylation variability in the population of healthy individuals, 78
DMPs were observed in the control group as well. 79
DMGs were estimated from group comparisons for number of DMPs within gene-body 80 regions between control (CD19+ blood cell donors) and ALL cells based on generalized linear 81 regression. This analysis yielded a total of 4795 DMGs, including protein-coding regions (3338) 82 and non-coding RNA genes ( Supplementary Table S1 ). 1774 genes from the set of 2360 reported 83 (B-Cells) DEGs in the original study 7 were DMGs as well (75.2%, Supplementary Table S2 ). 84
The gene-body methylation signal detected in PALL patients coincided with a significant 85 number of genes from the list of all cancer consensus genes (723) from the COSMIC database 8 : 86 Network analysis on a set of differentially methylated genes (DMGs) 88 When applying network analysis, not all DMGs and DEGs estimated from the 89 experimental datasets integrate networks. A subset of the most relevant genes from the 90 experimental dataset able to integrate networks is helpful to facilitate further network analysis. 91
The preliminary application of network-based enrichment analysis (NBEA 9 ) and network 92 enrichment analysis test (NEAT 10 ) on the set of DMGs permitted the identification of 285 93 network-related DMGs (Supplementary Tables S1 and S1). Similar analysis permitted the 94 identification of 326 network-related DEGs ( Supplementary Table S2 -B, from B-Cells 2360 95
DEGs reported in Supplementary Table 3 from original study 7 ). These subsets were used to 96 build the corresponding protein-protein interaction (PPI) networks with the STRING app of 97 Cytoscape 11,12 . Alternatively, to bypass possible bias introduced by the heuristic used to subset 98 the whole set of genes (NBEA 9 and NEAT 10 ), sub-clusters of hubs where retrieved applying the 99 MCODE Cytoscape app on the whole set of DMGs. 100
The PPI network built on the set of 285 DMGs is presented in Supplementary Fig. S2 .
101
The analysis with available tools in Cytoscape 11 led to the identification of the main hubs from 102 6 subnetwork of hubs identified KEGG pathways involved in cancer development ( Fig. 1B identified with NBEA 9 and NEAT 10 tests. The size of each node is proportional to its value of 116 betweeness centrality and the label font size is proportional to its node degree. Node colors from light-117 green to red maps the discrete scale of logarithm base 2 of fold changes in DMP numbers for the 118 corresponding gene: light-green: [1, 2), cyan: [2, 3), blue: [3, 4), and red: 5 or more. Edge color is based 119 on co-expression index from white (0.042) to red (0.842). B, enrichment analysis with Cytoscape 11 on 120 KEGG pathway sets on network in A. C, main subnetwork of hubs obtained with the application of Results of network enrichment analysis of DMG and DEG PPI networks built with 147 STRING (Cytoscape) are shown in Fig. 3 ( Supplementary Tables S1 an S2 ). The analyses 148 indicate that DMG and DEG datasets targeted many of the same pathways with overlap of 80% 149 ( Fig. 3C ). Pathways linked to cancer development and apoptosis are notable, and KEGG 150 pathways in cancer (hsa05200) showed pronounced enrichment, with more than 50 and 40 genes 151 from the DMG and DEG datasets, respectively. 152 Although only 51 enhancers from the 325 identified DMERs are activators of reported DEGs 243 ( Supplementary Table S2 ), the list of DEG-DMG regions covered by DMERs (in at least 500bp) 244 reach a total of 159 ( Fig. 6B ), from which 23 were identified oncogenes. 245
The top 29 genes with highest density variation of DMP number within enhancer regions 246 are shown in Figure 7 . Many of these genes have been reported to be associated with cancer 247 development and were found in the sets of DMGs or DEGs. One example is the enhancer region 248 influencing gene EPIDERMAL GROWTH FACTOR-LIKE DOMAIN 7 (EGFL7) and the micro-249
RNA MIR-126, both associated with cancer 23,24 . As shown in Figure 7B The association between methylation and gene expression for the current study of patients 272 with PALL is shown in Supplementary Fig. S7 . This association is not only corroborated by a 273 highly significant Spearman's rank correlation rho (p-value lesser than 0.001, Supplementary 274 values of X). This linear trend is noticed with high joint probability in the outlined contour-plot 286 red regions ( Supplementary Fig. S7 ). 287
PC-score of DEG-DMGs
288
The identification of genes playing fundamental roles in cancer progression is limited by the 289 availability of protein-protein interaction information in a database (STRING, in the current 290 case). Consequently, results could be mostly populated with genes from network-associated 291 diseases. To circumvent these possible limitations, principal component analysis (PCA) was 292 applied to score genes according to their discriminatory power to discern the disease state from 293 healthy. PCA was performed on the set of individuals, representing each in the 1775-dimensional 294 space DEGs-DMGs, where each gene was represented by the density of an information 295 divergence on gene-body, which provides a normalized measurement of the intensity of the 296 methylation signal. Two PC-scores were derived from two information divergences: 1) absolute 297 difference of methylation levels and 2) Hellinger divergence. 298
The first principal component (PC1) was used to build the PC-scores for DMGs, since it 299 carried 85% of the whole sample variance with eigenvalues greater than 1 (Guttman-Kaiser 300 criterion 30 , see Methods). A list of the first 12 genes with top PPI-network PC-scores is 301 presented in Table 1 , indicating genes associated with cancer development and further 302 confirming that regardless of approach followed, genes involved with cancer origin and 303 progression are DEG-DMGs. 304 hubs carrying the highest network centrality measurements ( Fig. 1 and 5) . Presumably, 315 disruption of a network hub by altering the gene, or others that regulate the hub, could alter the 316 entire gene network 14,31 . Thus, identification of hubs offers candidate targets in the search for 317 potential biomarkers. The strong linearity trends observed in pairwise regression between the 318 centrality measurements (Fig. 2) in the main hub cluster (Fig. 1A) suggests that genes from the 319 cluster are non-randomly targeted by the action of methylation regulatory machinery during 320 PALL development 14 . 321
Discussion
Clusters of hubs integrating PPI subnetworks comprise the backbone of a network. The 322 essentiality of gene hubs in preserving the integrity of the interacting network is quantitatively 323 expressed in network centrality statistics. For sub-networks of hubs ( Fig. 1 and 5) , higher 324 centrality values and linear relationships between the centrality statistics of the network hubs reflects a higher number of reported biologically meaningful associations between the hubs and 326 the other genes on the sub-network and the main network (Fig. 2) . 327
Strong correspondence was seen in the network enrichment analyses derived from PPI 328 networks in DMGs and DEGs (Fig. 3) in the case of the EGFR gene, identified as a hub in the DMG network (Fig. 1) . EFGR is a 336 tyrosine kinase that regulates autophagy via the PI3K/AKT1/mTOR, RAS/MAPK1/3 (enriched 337 pathways shown in Fig. 3A and B , and in Fig. 5A and E) , and STAT3 signaling pathways 32, 33 . 338
Although EGFR was not a reported DEG, its activators, EPIDERMAL GROWTH FACTOR 339 (EGF, Fig. 5B ) and EGFL7 were identified as both DMGs and DEGs. EGFL7 is reported to be a 340 key factor for the regulation of the EGFR signaling pathway 34 . Additionally, EGFL7 is a 341 secreted angiogenic factor that can result in pathologic angiogenesis and enhance tumor 342 migration and invasion via the NOTCH signaling pathway 23 (a pathway enriched in the PPI-343 DMG network). The NOTCH pathway is a conserved intercellular signaling pathway that 344 regulates interactions between physically adjacent cells. In the set of patients with PALL, network hub, Fig. 1 integrate to a PPI network, but is found in signaling pathways or regulators from them. As in the 360 previous analyses, enhancer methylation repatterning identifies genes known to be involved in 361 cancer development (Fig. 6B ). For example, SMARCA4 (Fig. 7) encodes an ATPase of the 362 chromatin remodeling SWI/SNF complexes frequently found upregulated in tumors 38 and 363 represents a DEG-DMG in patients with PALL. The product of this gene can bind BRCA1 364 (DEG-DMG) 39 and also regulates the expression of the tumorigenic protein CD44 (DEG-DMG) 365 40 . 366 PPI networks are only models to identify highly interconnected players from the subjacent 367 web architecture of genes involved in a specific biological process. Thus, results from the 368 application of more than one network model can complement, and different network models do 369 not necessarily overlap 100% with the set of enriched pathways. Deriving subsets of the DEG-370 DMG dataset by applying MCODE clustering increased confidence over previous results.
The integrative analyses of DMGs, DEGs and the networks derived from them, as well as 372
DMERs (graphically summarized in Fig. 1 to 7) , provided consistent indication of a web of 373 interacting genes in cancer development and an association between gene methylation 374 repatterning and gene expression changes. This association was supported by Spearman's rank 375 correlation rho and the bivariate FGM copula ( Supplementary Fig. S7 Supplementary Fig. S7 ). This result 383 may be indication that the relationship between gene methylation repatterning and altered gene 384 expression would be present at lower density methylation levels. Such a relationship can be 385 overlooked with over-stringent filtering of methylome data. Three analytical approaches assist in 386 discovering this association: i) signal detection for DMP identification, ii) GLM-based group 387 comparison for DMG identification, and iii) copula modeling of stochastic dependence. 388
Our results demonstrate the potential of integrative network analysis of DMGs and DEGs 389 for the identification of biologically relevant methylation biomarkers. Numerous clusters of 390 interacting genes are detected in the sub-networks of hubs from PPI networks of DMGs and 391
DEGs, a few of which are described here. More detailed analysis of these data has allowed us to 392 propose three factors likely to be important to biomarker identification. A potential biomarker 393 must 1) be a DMG or a DEG-DMG with one or more well defined differential methylation 394 pattern(s) on gene-body, upstream or downstream of the gene-body; 2) integrate one or more 395 gene pathways that are biologically relevant for leukemia and, simultaneously, show enrichment 396 in the PPI networks of DMGs and DEGs, and 3) represent a hub or be biologically connected to 397 a relevant hub. Genes holding to these guidelines integrate the subnetworks of hubs shown in 398
Figs. 1B and 4C-D, and the list of potential biomarkers can be extended using the information 399 provided in the Supplementary Tables S1 and S2. 400
Intersection of the identified networks with available data from independent studies of 401 cancer further supports the potential of our approach for identifying robust disease biomarkers. 402
However, while intersection of methylome and gene expression data with cancer-relevant gene 403
networks is compelling, we cannot eliminate the possibility that these outcomes may be 404 influenced by the relative abundance of cancer-related networks within the various databases 405 currently available. To help circumvent this limitation, we proposed ranking the DEG-DMGs 406 based on their discriminatory power to discern disease state from healthy. 407 Potential biomarkers can be scored with the application of PCA (Table 1 and 408 Supplementary Table S2 ). In this study, the first PC was sufficient to build a PC-score of DEG-409 DMGs based on gene-body methylation signal intensity. PC-scores identify cancer-related genes 410 not identified by the PPI network approach, although not all relevant genes were identifiable, 411 e.g., NOTCH1. Within a long gene like NOTCH1, the non-homogenous distribution of gene 412 body methylation signal (Fig. 6A) can result in apparently low density methylation signal 413 globally, even when signal is high locally. Nevertheless, PC-score provides an acceptable 414 complement to the PPI network approach. Results obtained with the approach proposed here 415 support its application to the identification of reliable and stable biomarkers for cancer diagnosis 416 and prognosis. Lists of genes relevant as biomarker candidates for leukemia (several of which 417 have already been proposed as biomarkers by others) are provided in the Supplementary Tables  418   online. 419 tests [42] [43] [44] . That is, optimal cutoff values of the methylation signal were estimated on the receiver 440 operating characteristic curves (ROCs) based on 'Youden Index' 42 and applied to identify DMPs. 441
Materials and Methods
420
Methylation and gene expression datasets
The decision of whether a DMP is detected by Fisher's exact test (or any other statistical test 442 implemented in Methyl-IT) is based on optimal cutoff value 43 . 443 The methylation analysis of genomic regions to identify differentially methylated enhancer 463 regions (DMERs) was performed on a set of enhancers reported by Hnisz et al. 46 . Usually, the 464 size of the genomic region covered by an enhancer varies depending on the tissue type. In our 465 current case, for each enhancer we analyzed the maximum region spanning all reported sizes for 466 different tissues. 467
Estimation of differentially methylated regions (DMRs
Network analysis
468 Protein-protein interaction (PPI) networks were built with STRING app of Cytoscape 11,12 . 469 Network analysis were conducted in Cytoscape. When the number of genes exceeded l00 for 470 network analysis, biologically meaningful web connections were difficult to visualize. 471
Biologically relevant subsets of genes were obtained from the whole set of genes (DMGs, DEG, 472 or DEGs-DMGs) by using the R packages NBEA and NEAT 9,10 . Alternatively, Cytoscape app 473 MCODE was then used for subsetting an entire network 47 . PPI subnetworks from four network 474 modules identified with MCODE are shown. MCODE parameters for degree cutoff: 10, node 475 density cutoff: 0.01, node score cutoff: 0.2, K-score 10, and max. depth: 100. K-mean clustering 476 algorithm was applied to each subnetwork to obtain subnetworks of hubs using the following 477 node attributes for clustering: betweenness-centrality, degree, closeness-centrality, and 478 clustering coefficient. 479
Network hubs were identified based on betweenness-centrality and node degree, where 480 size of each node (in PPI network) is proportional to its value of betweenness-centrality and label 481 font size is proportional to its node degree. To perform the concordance test, a score was assigned to each enriched KEGG pathway 491 from DEGs and DMGs based on the number of genes in the pathway and on its corresponding 492 statistical signification based on its FDR p-value. Only pathways with FDR p-value lesser than 493 0.0004 were considered. A new variable, statistical signification (sig) was defined according 494 with the scale:
= 1, 2, 3, for p-values in the intervals (10 −5 , 10 −4 ), (10 −6 , 10 −5 ), and 495 (0, 10 −6 ), respectively. The valor of = 0 was assigned to pathways not enriched in one of 496 the group, DEGs or DMGs. For example, Phosphatidylinositol signaling system was not 497 enriched in the set of PPI-DMGs and, consequently = 0, but it was enriched in the set of 498 PPI-DEGs with = 3. Then, a new variable, named pathway score was defined according 499 to the formula: 500
We would use the notation to indicate that the rating was performed for pathway 502 identified on the gene set k (k =DMGs, DEGs). That is, the pathway score P not only carries 503 information on how many genes are found on each pathway but also information on the 504 enrichment statistical signification. The estimated values of and for each enriched 505 pathway (from DEGs and DMGs sets, respectively) were used in the concordance tests and in 506 the Bland-Altman plot (Fig. 3E) . 507
Stochastic association between methylation and gene expression 508
To investigate such an association, the methylation density of gene regions simultaneously 509 identified as DEGs and DMGs were expressed in terms of different magnitudes: 1)
, 510 density of methylation levels (i: control or patients); 2)
, density of the difference of 511 methylation levels between each group (control or patients) and an independent group of four 512 healthy individuals (reference group); 3)
, with Bayesian correction, and 4) 513 , density of Hellinger divergence, where i denotes the group mean, control or patient. 514
The density in 1000 bp of a variable X at a given gene region was defined as the sum of the 515 magnitude X divided by the length of the region and multiplied by 1000. The differences of 516 methylation densities between control and patient groups were estimated as the absolute 517 Spearman's rank correlation (rho) was estimated to evaluate the association between the 522 pairs of variable |∆ 2 | versus: �∆ �, �∆ �, �∆ �, and �∆ �. 523
Since correlation analysis only measures the degree of dependence (mainly linear) but does not 524 clearly discover the structure of dependence, we further investigate the structural dependence 525 between these variables with application of Farlie-Gumbel-Morgenstern (FGM) copula. FGM 526 copula model estimation was performed with R package copula 50 . 527
Principal component analysis (PCA)
528
PCA is standard statistical procedure to reduce data dimensionality, to represent the set of DMGs 529 by new orthogonal (uncorrelated) variables, the principal components (PCs) 51 , and to identify 530 the variables with the main contribution to the PCs carrying most the sample variance. Herein, a 531 PC-based score (PC-score) was built by ranking the DEG-DMGs based on its discriminatory 532 power to discern between the disease state and healthy. Each individual was represented as 533 vector of the 1775-dimensional space of DEG-DMGs. Two PC-scores were estimated: the first 534 based on the density of Hellinger divergence on the gene-body and the second one based on the 535 density of the absolute value of methylation levels difference. The density of a magnitude x is 536 defined as the sum of x at each DMP divided by the gene width (in base-pairs). The first 537 principal component (PC1) was used to build a PC-based score for the DEG-DMG set, since it 538 had an eigenvalues (variance) greater than 1 and carried more than 85% of the whole sample 539 variance (Guttman-Kaiser criterion 30 ). The PC-score was built using the absolute values of the 540 coefficients (loadings) in PC1 for each variable (gene). Since the sum of the squared of variable 541 loadings over a principal component is equal to 1, the squared loadings tell us the proportion of 542 variance of one variable explained by the given principal component. Thus, the greater is the PC-543 score value, the greater will be the discriminatory power carried by the gene. 544
The density of HD on the gene-body was computed with MethylIT function 545 getGRegionsStat and the principal component with function pcaLDA, which conveniently 546 applies the PCA calling function prcomp from the R package 'stats'. 
